南方医科大学学报

南方医科大学学报 ›› 2014, Vol. 34 ›› Issue (12): 1809-.

• • 上一篇    下一篇

Treg/Th17细胞及相关细胞因子在Graves眼病中的作用及机制

吕蒙，沈洁，李章芳，赵德福，陈志，万亨，郝宝珺   

  • 出版日期:2014-12-20 发布日期:2014-12-20

Role of Treg/Th17 cells and related cytokines in Graves’ ophthalmopathy

  • Online:2014-12-20 Published:2014-12-20

PDF

1493

摘要： 目的探讨CD4+CD25+Foxp3+Treg/CD4+IL-17A+Th17细胞及相关细胞因子在Graves眼病中的作用及机制。方法根据临
床活动性评分（CAS）将未经治疗的Graves眼病患者分为活动性GO组（AGO组）15例（CAS≥3），非活动性GO组（NGO组）15例
（CAS<3）；同时选取未经治疗的同期非突眼Graves病患者（GD组）15例及健康对照组（C组）15例。收集各组病人外周静脉血，
采用流式细胞计数检测Treg、Th17细胞比例的变化；采用荧光定量PCR (RT-PCR)检测Treg特异性转录因子Foxp3及Th17特异
性转录因子RORγt 的表达情况；使用双抗体夹心酶免疫吸附法(ELISA)检测外周血血清中Treg 相关细胞因子TGF-β、IL-10、
IL-35以及Th17相关细胞因子IL-17A、IL-23、IL-6的表达变化。结果GD组、NGO组、AGO组中Th17细胞比例较C组升高（P<
0.05），且AGO组升高最明显。RORγt在GD组、NGO组、AGO组中升高（P<0.05），其中AGO组升高最明显。TGF-β、IL-35在
GD组、NGO组、AGO组中表达下降（P<0.05），IL-10在3组中表达升高（P<0.05）；GD组、NGO组、AGO组中IL-17A、IL-23、IL-6
蛋白较C组比较升高（P<0.05），且AGO组中升高更明显（P<0.05）。结论Treg 细胞免疫抑制功能的降低可能是促使Graves眼
病发生的一个重要因素。Th17细胞可能参与介导Graves眼病的发生与发展，Th17细胞及相关细胞因子可能是评估GO患者病
情活动性的新指标。Treg/Th17平衡的破坏可能参与Graves眼病的发病。

Abstract: Objective To explore the role of CD4+CD25+Foxp3+Treg/CD4+IL-17A+Th17 cells and the related cytokines in Graves’
ophthalmopathy. Methods Based on clinical activity scores (CAS), we divided patients with untreated Graves’ ophthalmopathy
into active group (AGO group with CAS≥3 (15 cases) and non-active group (NGO group) with CAS<3 (15 cases),
with another 15 patients with untreated Graves’ disease free of eye symptoms (GD group) and 15 normal subjects as controls.
Peripheral venous blood Treg/Th17 cell ratio was determined using flow cytometry. RT-PCR was used to detect the mRNA
expression levels of Treg-specific transcription factor Foxp3 and Th17-specific transcription factor RORγt. Enzyme-linked
immunosorbent assay (ELISA) was used to detect the serum levels of Th17 cell-related cytokines (IL-17A, IL-23, and IL-6) and
Treg-related cytokines (TGF-β, IL-10, and IL-35). Results Compared with the normal subjects, the patients in GD, NGO, AGO
groups all showed significantly increased Th17 cell count (P<0.05), which was the highest in AGO group. RT-PCR results
revealed significantly increased RORγt in GD, NGO, and AGO groups, also the highest in AGO group. Serum IL-17A, IL-23,
and IL-6 levels all showed significant increments in GD, NGO, and AGO groups (P<0.05), especially in AGO group. Among the
Treg-related cytokines, TGF-β and IL-35 levels decreased (P<0.05) but IL-10 increased significantly (P<0.05) in GD, NGO, AGO
groups. Conclusion Decreased immunosuppressive capacity of Treg cells can be an important factor in the pathogenesis of
Graves’ ophthalmopathy. Th17 cells may also participate in the occurrence and progression of Graves’ ophthalmopathy and
can serve along with related cytokines as novel indicators of the disease activity. Impaired Treg/Th17 balance may importantly
contribute to the occurrence of Graves’ ophthalmopathy.